Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market
Holding CVKD?
Track your performance easily

Cadrenal Therapeutics, Inc. (CVKD) Income Statement

107 Followers

Cadrenal Therapeutics, Inc. Income Statement

Last quarter (Q2 2024), Cadrenal Therapeutics, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Cadrenal Therapeutics, Inc.'s net income was $-2.39M. See Cadrenal Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
$ 220.09K$ 220.09K-
Gross Profit
$ -220.09K$ -220.09K-
Operating Expense
$ 11.52M$ 7.63M$ -2.70M
Operating Income
$ -15.04M$ -7.63M$ -2.77M
Net Non Operating Interest Income Expense
$ -26.71K$ -231.99K$ -40.19K
Other Income Expense
$ 1.69M$ -956.23K$ 3.91M
Pretax Income
$ -13.26M$ -8.36M$ -6.71M
Tax Provision
$ -1.75M$ -1.75M$ 0.00
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -16.58M$ -8.36M$ -6.71M
Basic EPS
$ -1.06$ -0.62$ -0.85
Diluted EPS
$ -1.06$ -0.62$ -0.85
Basic Average Shares
$ 63.49M$ 13.49M$ 7.89M
Diluted Average Shares
$ 63.49M$ 13.49M$ 7.89M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 11.74M$ 7.63M$ -2.70M
Net Income From Continuing And Discontinued Operation
$ -16.58M$ -8.36M$ -6.71M
Normalized Income
$ -9.58M$ -5.43M-
Interest Expense
---
EBIT
$ -13.25M$ -8.34M$ -6.67M
EBITDA
$ -13.25M$ -8.34M$ -6.61M
Currency in USD

Cadrenal Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis